Skip to main content
Figure 1 | Journal of Experimental & Clinical Cancer Research

Figure 1

From: Bostrycin inhibits proliferation of human lung carcinoma A549 cells via downregulation of the PI3K/Akt pathway

Figure 1

Effect of Bostrycin on the proliferation of A549 cells by MTT assay. A549 cells were treated with 10, 20, or 30 μM of bostrycin for 24 h, 48 h or 72 h. Negative control consisted of untreated cells, while the blank control was set up with only medium. Statistically significant differences were observed between groups treated with different bostrycin concentrations at each time point and between different time points at each concentration (all P < 0.05).

Back to article page